Matches in Nanopublications for { ?s ?p "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP454080.RAUWmE4DC03WshShRpcLlnDNzA-hR6oxfzjoxsNSz3vdY130_assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454080.RAUWmE4DC03WshShRpcLlnDNzA-hR6oxfzjoxsNSz3vdY130_provenance.
- NP73826.RApsLuQ6yboQfiYc1NS7qE78YPsN52CLA2tDrL5ga_50E130_assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73826.RApsLuQ6yboQfiYc1NS7qE78YPsN52CLA2tDrL5ga_50E130_provenance.
- assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP689796.RAV8rkvoY1CXcNrJs2F8mGbKnTdfW75j82aEcMe-sf3lc130_assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689796.RAV8rkvoY1CXcNrJs2F8mGbKnTdfW75j82aEcMe-sf3lc130_provenance.
- NP453511.RArD7VMGKBU-qoSfNDRGD9hBYqRh6e12TVxI5GjQEgNZw130_assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453511.RArD7VMGKBU-qoSfNDRGD9hBYqRh6e12TVxI5GjQEgNZw130_provenance.
- NP689797.RAI9DHOO4qbTCWKTarjPGhlsTw_imakZSMstu6DRAR-Kc130_assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689797.RAI9DHOO4qbTCWKTarjPGhlsTw_imakZSMstu6DRAR-Kc130_provenance.
- NP689795.RA6xFgDdwgD8tsWmbqcWYDr2QCB8CqP3qTydMWK60pGXs130_assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689795.RA6xFgDdwgD8tsWmbqcWYDr2QCB8CqP3qTydMWK60pGXs130_provenance.
- NP129114.RAzs-Fj859yg5Zmve535cvnvAHACXN1KD1FgmkBatz-uI130_assertion description "[HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129114.RAzs-Fj859yg5Zmve535cvnvAHACXN1KD1FgmkBatz-uI130_provenance.